Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer

Clinical trial NCT06359847 · RECRUITING

Trial details

NCT number: NCT06359847
Sponsor: Beijing Scitech-Mq Pharmaceuticals Limited
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Differentiated Thyroid Carcinoma

Start date: 2023-11-15
Primary completion: 2027-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.